Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 872 studies with search of: | "Paraproteinemias" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
21 | Completed |
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
|
||||
22 | Recruiting |
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
|
||||
23 | Recruiting |
Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
|
||||
24 | Completed |
The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma
|
||||
25 | Recruiting |
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
|
||||
26 | Recruiting |
Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment
|
||||
27 | Recruiting |
Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
|
||||
28 | Suspended |
Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma
|
||||
29 | Recruiting |
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
|
||||
30 | Recruiting |
Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma
|
||||
31 | Recruiting |
Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
|
||||
32 | Recruiting |
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
|
||||
33 | Recruiting |
Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
|
||||
34 | Completed |
Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
|
||||
35 | Completed |
Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma
|
||||
36 | Active, not recruiting |
Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
|
||||
37 | Completed |
Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy
|
||||
38 | Active, not recruiting |
T-Cell Depletion, Donor Stem Cell Transplant, and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
|
||||
39 | Active, not recruiting |
This is a Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor in Patients With Multiple Myeloma
|
||||
40 | Recruiting |
Trial of Romidepsin and Bortezomib for Multiple Myeloma
|
Previous Page (1-20) | Studies Shown (21-40) | Next (41-60) |